A 3D-printed miniature model of Elon Musk and the Neuralink logo are seen in this illustration taken January 23, 2025. REUTERS/Dado Ruvic/Illustration
(Reuters) - Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.
The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it said in a post on X.
